Correlation Between Ikena Oncology and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Ikena Oncology and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Cyclacel Pharmaceuticals.
Diversification Opportunities for Ikena Oncology and Cyclacel Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ikena and Cyclacel is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ikena Oncology and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.13 times more return on investment than Cyclacel Pharmaceuticals. However, Ikena Oncology is 7.96 times less risky than Cyclacel Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest 173.00 in Ikena Oncology on August 29, 2024 and sell it today you would lose (2.00) from holding Ikena Oncology or give up 1.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.67% |
| Values | Daily Returns |
Ikena Oncology vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Ikena Oncology |
| Cyclacel Pharmaceuticals |
Ikena Oncology and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Ikena Oncology and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |